Endocrinology Search
Endocrinology Endocrinology
osteoporosis
OSTEOPOROSIS
Osteoporosis is the progressive, systemic skeletal disease characterized by decreased bone mass and micro-architectural deterioration of bone tissue leading to increased bone fragility and susceptibility to fractures.
The more risk factors (eg history, of fracture, advanced age, comorbidities, impaired vision) that are present, the greater the risk of fracture.
Drug Information

Indication: Treatment & prevention of vit D deficiency. Adjunctive treatment for osteoporosis. Reduces risk of falling...

Indication: Ca dietary supplement.

Indication: Correction of combined vit D & Ca deficiency in the elderly. Adjunct to treatment of osteoporosis in patie...

Indication: Health supplement.

Indication: Osteoporosis in postmenopausal women & prevents fractures in men.

Indication: Testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clin...

Indication: Postmenopausal osteoporosis. Reduce risk of vertebral & hip fractures.

Indication: Postmenopausal osteoporosis, to reduce the risk of fractures.

Calcium with Vitamin D Plus YSP
calcium carbonate + vitamin D

Indication: Dietary supplement.

Calcium with Vitamin D YSP
calcium + vitamin D3

Indication: Prevention of Ca deficiency.

1  /  6
1  /  6
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Semaglutide helps lower HbA1c, body weight of T2D patients
Stephen Padilla, 03 Feb 2020
Treatment with semaglutide leads to clinically significant decreases in haemoglobin A1C (HbA1c) and body weight in patients with type 2 diabetes (T2D) across the SUSTAIN 1–7 trials, regardless of race and ethnicity, results of a posthoc analysis have shown.
Another role for SGLT2is: Gout prevention?
Roshini Claire Anthony, 28 Jan 2020

Individuals with type 2 diabetes (T2D) who are prescribed an SGLT2* inhibitor may have a reduced risk for developing gout compared with those who are prescribed a GLP-1** receptor agonist, according to a study from the US.
Bariatric surgery may prevent diabetes onset in obese, nondiabetic Asians
Jairia Dela Cruz, 27 Jan 2020
Bariatric surgery is beneficial to nondiabetic Asian patients with obesity, delivering sustained weight loss in addition to normalizing sugar levels and insulin resistance within 1–3 years of the procedure, as reported in a Singapore study.
Gestational diabetes confers long-term type 2 diabetes risk
06 Feb 2020
The long-term risk of type 2 diabetes or impaired glucose tolerance is common in women with gestational diabetes, reports a new China study.